Publication Name	World Journal of Clinical Oncology
Manuscript ID	89352
Country	China

Received	2023-10-29 02:00
Peer-Review Started	2023-10-29 02:02
To Make the First Decision
Return for Revision	2023-12-22 03:14
Revised	2024-01-05 14:02
Second Decision	2024-02-04 03:04
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2024-02-04 06:57
Articles in Press	2024-02-04 06:57
Publication Fee Transferred
Edit the Manuscript by Language Editor	2024-02-09 02:14
Typeset the Manuscript	2024-03-05 06:42
Publish the Manuscript Online	2024-03-22 11:48

ISSN	2218-4333 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Meta-Analysis
Article Title	Transarterial chemoembolization plus stent for hepatocellular carcinoma with main portal vein tumor thrombosis: A meta-analysis
Manuscript Source	Unsolicited Manuscript
All Author List	Wei-Fan Sui, Jian-Yun Li and Jian-Hua Fu
ORCID	Author(s) ORCID Number Wei-Fan Sui http://orcid.org/0000-0002-2732-9565 Jian-Yun Li http://orcid.org/0000-0003-2733-9566 Jian-Hua Fu http://orcid.org/0000-0003-4380-129X
Funding Agency and Grant Number
Corresponding Author	Jian-Hua Fu, Doctor, Director, Interventional Radiology, Zhenjiang First People's Hospital, No. 8 Dianli Road, Zhenjiang 212000, Jiangsu Province, China. suiweifan@126.com
Key Words	Hepatocellular carcinoma; Transarterial chemoembolization; Portal vein tumor thrombus; Stent; Meta-analysis
Core Tip	Portal vein tumor thrombus (PVTT) as an important indicator of poor prognosis existed in 44% of patients with hepatocellular carcinoma (HCC). Transarterial chemoembolization (TACE) is recommended as the standard first-line therapy in unresectable hepatocellular carcinoma. Some Chinese scholars showed that TACE combined with portal vein stent placement was safe and could prolong the survival time in HCC patients with PVTT.
Publish Date	2024-03-22 11:48
Citation	Sui WF, Li JY, Fu JH. Transarterial chemoembolization plus stent for hepatocellular carcinoma with main portal vein tumor thrombosis: A meta-analysis. World J Clin Oncol 2024; 15(3): 447-455
URL	https://www.wjgnet.com/2218-4333/full/v15/i3/447.htm
DOI	https://dx.doi.org/10.5306/wjco.v15.i3.447

Full Article (PDF)	WJCO-15-447-with-cover.pdf
PRISMA 2009 Checklist	89352-PRISMA 2009 checklist.pdf
Manuscript File	89352_Auto_Edited-YJP_WangTQ.docx
Answering Reviewers	89352-Answering reviewers.pdf
Audio Core Tip	89352-Audio core tip.m4a
Biostatistics Review Certificate	89352-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	89352-Conflict-of-interest statement.pdf
Copyright License Agreement	89352-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	89352-Language certificate.pdf
Peer-review Report	89352-Peer-review(s).pdf
Scientific Misconduct Check	89352-CrossCheck.png
Scientific Misconduct Check	89352-Bing-Gong ZM-2.png
Scientific Editor Work List	89352-Scientific editor work list.pdf